Q3 2023 EPS Estimates for Agilent Technologies, Inc. (NYSE:A) Increased by Jefferies Financial Group

Agilent Technologies, Inc. (NYSE:AGet Rating) – Analysts at Jefferies Financial Group raised their Q3 2023 EPS estimates for shares of Agilent Technologies in a research report issued to clients and investors on Tuesday, November 22nd. Jefferies Financial Group analyst B. Couillard now forecasts that the medical research company will post earnings of $1.44 per share for the quarter, up from their prior estimate of $1.41. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.64 per share. Jefferies Financial Group also issued estimates for Agilent Technologies’ Q4 2023 earnings at $1.68 EPS and FY2023 earnings at $5.65 EPS.

Other analysts have also recently issued research reports about the stock. Cowen raised their price objective on shares of Agilent Technologies from $160.00 to $168.00 in a research report on Tuesday. SVB Leerink increased their price objective on Agilent Technologies from $145.00 to $160.00 and gave the company an “outperform” rating in a research report on Tuesday. Wells Fargo & Company boosted their target price on Agilent Technologies from $135.00 to $150.00 in a research report on Tuesday. Robert W. Baird increased their price target on shares of Agilent Technologies from $160.00 to $170.00 in a research report on Tuesday. Finally, Evercore ISI upped their price objective on shares of Agilent Technologies from $140.00 to $155.00 in a research note on Tuesday. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $157.00.

Agilent Technologies Price Performance

NYSE:A opened at $155.35 on Wednesday. Agilent Technologies has a 52-week low of $112.52 and a 52-week high of $162.62. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.41 and a current ratio of 2.03. The firm has a market capitalization of $45.99 billion, a price-to-earnings ratio of 37.25, a P/E/G ratio of 2.78 and a beta of 1.06. The stock has a fifty day moving average of $133.99 and a 200 day moving average of $128.48.

Agilent Technologies (NYSE:AGet Rating) last issued its earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.14. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.31%. The business had revenue of $1.85 billion for the quarter, compared to analysts’ expectations of $1.76 billion. During the same quarter in the previous year, the firm posted $1.21 EPS. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year.

Agilent Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be given a $0.225 dividend. The ex-dividend date is Friday, December 30th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.21. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.58%. Agilent Technologies’s payout ratio is 20.14%.

Insider Buying and Selling

In other news, CEO Michael R. Mcmullen sold 6,775 shares of the firm’s stock in a transaction dated Wednesday, October 19th. The shares were sold at an average price of $130.11, for a total value of $881,495.25. Following the transaction, the chief executive officer now directly owns 191,358 shares of the company’s stock, valued at $24,897,589.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 6,775 shares of Agilent Technologies stock in a transaction on Wednesday, October 19th. The stock was sold at an average price of $130.11, for a total value of $881,495.25. Following the sale, the chief executive officer now owns 191,358 shares in the company, valued at $24,897,589.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Padraig Mcdonnell sold 2,103 shares of the company’s stock in a transaction dated Wednesday, September 28th. The shares were sold at an average price of $122.89, for a total transaction of $258,437.67. Following the completion of the transaction, the vice president now directly owns 13,217 shares in the company, valued at approximately $1,624,237.13. The disclosure for this sale can be found here. In the last quarter, insiders sold 174,326 shares of company stock valued at $26,474,537.

Institutional Investors Weigh In On Agilent Technologies

Several large investors have recently added to or reduced their stakes in A. Toroso Investments LLC lifted its stake in Agilent Technologies by 9.6% in the third quarter. Toroso Investments LLC now owns 6,568 shares of the medical research company’s stock worth $797,000 after acquiring an additional 577 shares during the last quarter. CVA Family Office LLC lifted its position in shares of Agilent Technologies by 722.2% during the 3rd quarter. CVA Family Office LLC now owns 370 shares of the medical research company’s stock worth $45,000 after purchasing an additional 325 shares during the last quarter. IHT Wealth Management LLC acquired a new position in shares of Agilent Technologies during the third quarter worth $359,000. B. Riley Wealth Advisors Inc. increased its holdings in Agilent Technologies by 5.8% in the third quarter. B. Riley Wealth Advisors Inc. now owns 5,086 shares of the medical research company’s stock valued at $619,000 after buying an additional 278 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky acquired a new stake in Agilent Technologies in the third quarter valued at $3,401,000.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Articles

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.